Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic index. Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection
Know More
Biomus is a potent immunosuppressive agent that is effective in allograft prophylaxis after organ transplantation, for therapy of acute rejection and in treatment of different immune diseases. Bioavailability range from 10-60%. Reaches maximum blood levels after 1-2 hours after dosing. Half-life ranges from 8-24 hours. Significantly reduces the incidence and severity of acute rejection rates…
Know More
Biomyf is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver transplants
Know More
Rapasim (Sirolimus) – a lipophilic macrolide immunosuppressant, which was isolated from a strain of fungus called Streptomyces hygroscopicus in 1972 September. The compound was originally named rapamycin – an antifungal agent. It was approved by the US Food and Drug Administration as an immunosuppressant in September 1999. Rapasim (Sirolimus) is used in combination with other…
Know More
Valniche is an antiviral medication used to treat cytomegalovirus infections. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterase
Know More
